Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest

Journal of Clinical Microbiology

Volumn 42, Issue 8, 2004, Pages 3589-3593

  Velegraki, Aristea ^a   Alexopoulos, Evangelos C ^a   Kritikou, Stavroula ^a   Gaitanis, George ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; POSACONAZOLE; TERBINAFINE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ARTICLE; CORRELATION COEFFICIENT; CULTURE MEDIUM; DRUG SENSITIVITY; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS ISOLATION; MALASSEZIA; MALASSEZIA DERMATIS; MALASSEZIA FURFUR; MALASSEZIA PACHYDERMATIS; MALASSEZIA RESTRICTA; MALASSEZIA SYMPODIALIS; METHODOLOGY; MICRODILUTION METHOD; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CULTURE MEDIA; FATTY ACIDS; HUMANS; MALASSEZIA; MICROBIAL SENSITIVITY TESTS; MYCOSES; TRIAZOLES;

FUNGI; MALASSEZIA; MALASSEZIA DERMATIS; MALASSEZIA FURFUR; MALASSEZIA PACHYDERMATIS; MALASSEZIA RESTRICTA; MALASSEZIA SYMPODIALIS;

EID: 3843085150     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.8.3589-3593.2004     Document Type: Article

References (23)

1. Arnow, P., and R. Kushner. 1991. Malassezia furfur catheter infection cured with antibiotic lock therapy. Am. J. Med. 90:128-130.
2. Brooks, R., and L. Brown. 1987. Systemic infection with Malassezia furfur in an adult receiving long-term hyperalimentation therapy. J. Infect. Dis. 156:410-411.
3. Gaitanis, G., A. Velegraki, E. Frangoulis, A. Mitroussia, A. Tsigonia, A. Tzimogianni, A. Katsambas, and N. J. Legakis. 2002. Identification of Malassezia species from patient skin scales by PCR-RFLP. Clin. Microbiol. Infect. 8:162-173.
4. Garau, M., M. Pereino, Jr., and A. del Palacio. 2003. In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds. Antimicrob. Agents Chemother. 47:2342-2344
5. Guého, E., G. Midgley, and J. Guillot. 1996. The genus Malassezia with description of four new species. Antonie Leeuwenhoek 69:337-355.
6. Guillot, J., E. Guého, M. Lesourd, G. Midgley, G. Chevrier, and B. Dupont. 1996. Identification of Malassezia species. A practical approach. 1996. J. Mycol. Med. 6:103-110.
7. Gupta, A. K., Y. Kohi, I. Li, J. Faergemann, and R. C. Summerbell. 2000. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine. Br. J. Dermatol. 142:758-765.
8. Leeming, J. P., and F. H. Notman. 1997. Improved methods for isolation and enumeration of Malassezia furfur from human skin. J. Clin. Microbiol. 25:2017-2019.
9. Marcon, M. J., D. E. Durrell, D. A. Powell, and W. J. Buesching. 1987. In vitro activity of systemic antifungal agents against Malassezia furfur. Antimicrob. Agents Chemother. 31:951-953.
10. Masure, O., C. Leostic, M. L. Abalain, C. Chastel, I. Yahoub-Agha, C. Berthou, and J. Brieve. 1991. Malassezia furfur septicemia in a child with leukemia. J. Infect. 23:335-336.
11. Mayser, P., P. Haze, C. Papavassilis, M. Pickel, K. Gruender, and E. Guého. 1997. Differentiation of Malassezia species: selectivity for cremophor E1, castor oil and ricinoleic acid for M. furfur. Br. J. Dermatol. 137:208-213.
12. Murai, T., Y. Nakamura, R. Kano, S. Watabane, and A. Hasegawa. 2002. Susceptibility testing of Malassezia pachydermatis using the urea broth microdilution method. Mycoses 28:84-87.
13. Nakamura, A., A. Kano, T. Mural, S. Watabane, and A. Hasegawa. 2000. Susceptibility testing of Malassezia species using the urea broth microdilution method. Antimicrob. Agents Chemother. 44:2185-2186.
14. NCCLS. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. NCCLS, Wayne, Pa.
15. Pfaller, M. A., S. A. Messer, A. Houston, K. Mills, and A. Bolmström. 2000. Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media. J. Clin. Microbiol. 38:3715-3717.
16. Pfaller, M. A., S. A. Messer, A. Karlsson, and A. Bolmström. 1998. Evaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media. J. Clin. Microbiol. 36:2586-2589.
17. Pfaller, M. A., S. A. Messer, K. Mills, A. Bolmström, and R. N. Jones. 2001. Evaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida species. J. Clin. Microbiol. 39:3952-3954.
18. Redline, R. W., S. S. Redline, B. Boxerboum, and B. Dahms Barett. 1985. Systemic Malassezia furfur infections in patients receiving intralipid therapy. Hum. Pathol. 16:815-822.
19. Schleman, K., G. Tullis, and R. Blum. 2000. Intracardiac mass complicating Malassezia furfur fungemia. Chest 118:1828-1829.
20. Schmidt, A., and B. Rühl-Hörster. 1996. In vitro susceptibility of Malassezia furfur against azole compounds. Mycoses 39:309-312.
21. Schoepfer, C., H. Carla, M. J. Bezou, M. Cambon, D. Girault, F. Demeocq, and G. Malpuech. 1995. Malassezia furfur septicemia after bone marrow graft. Arch. Pediatr. 2:245-248.
22. Sugita, T., M. Takashima, T. Shinoda, H. Suto, T. Unno, R. Tsuboi, H. Ogawa, and A. Nishikawa. 2002. New yeast species, Malassezia dermatis, isolated from patients with atopic dermatitis. J. Clin. Microbiol. 40:1363-1367.
23. Sugita, T., M. T. Takashima, M. Kodama, R. Tsuboi, and A. Nishikawa. 2003. Description of a new yeast species, Malassezia japonica, and its detection in patients with atopic dermatitis and healthy subjects. J. Clin. Microbiol. 41:4695-4699.